Press & media

Last updated: May 21, 2026

For journalists, analysts, and researchers. Fact sheet, founder bio, brand assets, and primary-source data points are below. For interviews, quote requests, or access to the underlying methodology, email editorial@carecostestimate.com.

One-line description

CareCost Estimate is a billing-and-coding reference and copay calculator for specialty medical practices, built on primary-source CMS pricing files and 42 billion rows of payer transparency data.

Fact sheet

Legal entity: CareCost LLC
Product: CareCost Estimate — specialty drug billing reference + patient cost calculator
Founded: 2026
Founder: Erin Rose
Headquarters: United States (available on request)
Audience: Specialty medical practices, infusion centers, oncology clinics, billers, coders, revenue-cycle staff
Pricing: $89 per seat per month during private beta; 20% founder-practice annual discount honored at general availability
Data scale: 42 billion rows of negotiated-rate data (payer Transparency-in-Coverage MRF files, 45 CFR Part 147)
Reference library: 115 specialty drug billing-and-coding pages, refreshed quarterly against CMS ASP files
Editorial contact: editorial@carecostestimate.com
Press contact: editorial@carecostestimate.com

What's distinctive about the data

Most specialty-drug billing references in the market are aggregations of secondary sources — commercial drug compendia, vendor catalogs, prior-year reimbursement claims. CareCost Estimate is assembled from primary sources directly:

CMS authoritative files at the active quarter: ASP Pricing File, NDC-HCPCS Crosswalk, HCPCS Long Descriptors, Medicare Physician Fee Schedule
FDA drug labeling sourced from openFDA
Payer Transparency-in-Coverage Machine-Readable Files published under 45 CFR Part 147 — 42 billion rows ingested, normalized, and de-duplicated against the contract-sample threshold described in our Methodology
Patient-assistance program data sourced directly from manufacturer and foundation pages, re-validated on a published cadence
Methodology validated against interviews with practicing billers, coders, and revenue-cycle staff at infusion centers and specialty practices

The source-conflict hierarchy, refresh cadence, and AI-use policy are documented in the Editorial Policy.

Founder

Erin Rose — Founder, CareCost LLC

Twenty years in digital media and ad-tech infrastructure. Ten years building healthcare-vertical products at USA Today / LocaliQ. Methodology and data architect for CareCost Estimate. Public speaker on healthcare media and data infrastructure.

For interviews: editorial@carecostestimate.com

LinkedIn →

Brand assets

Logo, wordmark, and icon files for editorial use. Please don't alter the artwork or use it to imply endorsement that hasn't been granted.

Copy-paste boilerplate

For use in articles, panel introductions, or filings. Please cite as "CareCost Estimate" on first reference; "CareCost" is acceptable on second reference.

Short (50 words)

CareCost Estimate is a billing-and-coding reference and copay calculator for specialty medical practices, built by CareCost LLC. The platform indexes 115 specialty drug references against CMS authoritative pricing files and 42 billion rows of payer transparency data, with methodology validated against interviews with practicing billers and revenue-cycle staff.

Long (120 words)

CareCost Estimate is a specialty-drug billing reference and patient cost calculator built for infusion centers, oncology practices, and specialty clinics. Founded in 2026 by Erin Rose, the platform indexes 115 specialty drug billing-and-coding references — each refreshed quarterly against current CMS ASP files, FDA labeling, and NCCI edits — alongside 42 billion rows of payer Transparency-in-Coverage Machine-Readable File data ingested under 45 CFR Part 147. Methodology is validated against interviews with practicing billers, coders, and revenue-cycle staff at specialty practices. CareCost Estimate accepts no manufacturer, payer, PBM, or foundation compensation; all program rankings are driven by drug-, diagnosis-, and insurance-eligibility match alone. The full source hierarchy and editorial standards are published.

Notable data points

Available for citation in articles on specialty drug pricing, payer transparency, or revenue-cycle topics. Methodology behind each figure is documented in the Methodology page.

42 billion rows. Volume of payer-published negotiated-rate records (Transparency-in-Coverage MRF files, 45 CFR Part 147) ingested and normalized by CareCost Estimate as of Q2 2026.

115 drugs. Active specialty drug billing-and-coding references in the CareCost library, each tied to current HCPCS, NDC, ICD-10, and payer policy data.

Quarterly refresh. CMS ASP Pricing File and Physician Fee Schedule are re-imported each quarter when CMS publishes new files; FDA labeling pulls run on the openFDA cadence.

Additional dataset statistics — rate-spread distributions, payer coverage gaps, negotiated-vs-public-price comparisons — are available on request for journalists working on specialty drug pricing stories. Email editorial@carecostestimate.com.

Editorial standards

CareCost Estimate publishes a full Editorial Policy covering source hierarchy, AI use, conflict-of-interest rules, correction handling, and review cadence. Each reference page carries a "Last reviewed" date and is re-reviewed at minimum annually even if no source has changed.

Corrections: editorial@carecostestimate.com. Confirmed corrections normally ship within five business days; corrections that affect a billing or coding decision in current use are prioritized.

Press contact

Interview requests, data point access, methodology questions: editorial@carecostestimate.com.

For editorial corrections or source-suggestions: editorial@carecostestimate.com.